A novel Osmium-based compound targets the mitochondria and triggers ROS-dependent apoptosis in colon carcinoma
Engagement of the mitochondrial-death amplification pathway is an essential component in chemotherapeutic execution of cancer cells. Therefore, identification of mitochondria-targeting agents has become an attractive avenue for novel drug discovery. Here, we report the anticancer activity of a novel...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Nature Publishing Group
2013
|
| Online Access: | http://hdl.handle.net/20.500.11937/51238 |